Click for best price
PET Radiopharmaceuticals Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for PET Radiopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PET Radiopharmaceuticals. This report contains market size and forecasts of PET Radiopharmaceuticals in global, including the following market information:
The global PET Radiopharmaceuticals market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
F-18 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of PET Radiopharmaceuticals include Cardinal Health Inc. (U.S.), Mallinckrodt plc (Ireland), GE Healthcare (U.K.), Lantheus Medical Imaging, Inc. (U.S.), Bayer AG (Germany), Bracco Imaging S.p.A (Italy), Eczacibasi-Monrol Nuclear Products (Turkey), Nordion, Inc. (Canada) and Advanced Accelerator Applications S.A. (France), etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the PET Radiopharmaceuticals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global PET Radiopharmaceuticals Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global PET Radiopharmaceuticals Market Segment Percentages, by Type, 2022 (%)
Global PET Radiopharmaceuticals Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global PET Radiopharmaceuticals Market Segment Percentages, by Application, 2022 (%)
- Oncology
- Cardiology
- Neurology
- Others
Global PET Radiopharmaceuticals Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global PET Radiopharmaceuticals Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies PET Radiopharmaceuticals revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies PET Radiopharmaceuticals revenues share in global market, 2022 (%)
- Key companies PET Radiopharmaceuticals sales in global market, 2018-2023 (Estimated), (K Pcs)
- Key companies PET Radiopharmaceuticals sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Cardinal Health Inc. (U.S.)
- Mallinckrodt plc (Ireland)
- GE Healthcare (U.K.)
- Lantheus Medical Imaging, Inc. (U.S.)
- Bayer AG (Germany)
- Bracco Imaging S.p.A (Italy)
- Eczacibasi-Monrol Nuclear Products (Turkey)
- Nordion, Inc. (Canada)
- Advanced Accelerator Applications S.A. (France)
- IBA Molecular Imaging (Belgium)
Outline of Major Chapters:
Chapter 1: Introduces the definition of PET Radiopharmaceuticals, market overview.
Chapter 2: Global PET Radiopharmaceuticals market size in revenue and volume.
Chapter 3: Detailed analysis of PET Radiopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of PET Radiopharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global PET Radiopharmaceuticals capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
PET Radiopharmaceuticals Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
74 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 PET Radiopharmaceuticals Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global PET Radiopharmaceuticals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global PET Radiopharmaceuticals Overall Market Size
2.1 Global PET Radiopharmaceuticals Market Size: 2022 VS 2030
2.2 Global PET Radiopharmaceuticals Revenue, Prospects & Forecasts: 2018-2030
2.3 Global PET Radiopharmaceuticals Sales: 2018-2030
3 Company Landscape
3.1 Top PET Radiopharmaceuticals Players in Global Market
3.2 Top Global PET Radiopharmaceuticals Companies Ranked by Revenue
3.3 Global PET Radiopharmaceuticals Revenue by Companies
3.4 Global PET Radiopharmaceuticals Sales by Companies
3.5 Global PET Radiopharmaceuticals Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 PET Radiopharmaceuticals Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers PET Radiopharmaceuticals Product Type
3.8 Tier 1, Tier 2 and Tier 3 PET Radiopharmaceuticals Players in Global Market
3.8.1 List of Global Tier 1 PET Radiopharmaceuticals Companies
3.8.2 List of Global Tier 2 and Tier 3 PET Radiopharmaceuticals Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global PET Radiopharmaceuticals Market Size Markets, 2022 & 2030
4.1.2 F-18
4.1.3 Ru-82
4.1.4 Others
4.2 By Type - Global PET Radiopharmaceuticals Revenue & Forecasts
4.2.1 By Type - Global PET Radiopharmaceuticals Revenue, 2018-2023
4.2.2 By Type - Global PET Radiopharmaceuticals Revenue, 2024-2030
4.2.3 By Type - Global PET Radiopharmaceuticals Revenue Market Share, 2018-2030
4.3 By Type - Global PET Radiopharmaceuticals Sales & Forecasts
4.3.1 By Type - Global PET Radiopharmaceuticals Sales, 2018-2023
4.3.2 By Type - Global PET Radiopharmaceuticals Sales, 2024-2030
4.3.3 By Type - Global PET Radiopharmaceuticals Sales Market Share, 2018-2030
4.4 By Type - Global PET Radiopharmaceuticals Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global PET Radiopharmaceuticals Market Size, 2022 & 2030
5.1.2 Oncology
5.1.3 Cardiology
5.1.4 Neurology
5.1.5 Others
5.2 By Application - Global PET Radiopharmaceuticals Revenue & Forecasts
5.2.1 By Application - Global PET Radiopharmaceuticals Revenue, 2018-2023
5.2.2 By Application - Global PET Radiopharmaceuticals Revenue, 2024-2030
5.2.3 By Application - Global PET Radiopharmaceuticals Revenue Market Share, 2018-2030
5.3 By Application - Global PET Radiopharmaceuticals Sales & Forecasts
5.3.1 By Application - Global PET Radiopharmaceuticals Sales, 2018-2023
5.3.2 By Application - Global PET Radiopharmaceuticals Sales, 2024-2030
5.3.3 By Application - Global PET Radiopharmaceuticals Sales Market Share, 2018-2030
5.4 By Application - Global PET Radiopharmaceuticals Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global PET Radiopharmaceuticals Market Size, 2022 & 2030
6.2 By Region - Global PET Radiopharmaceuticals Revenue & Forecasts
6.2.1 By Region - Global PET Radiopharmaceuticals Revenue, 2018-2023
6.2.2 By Region - Global PET Radiopharmaceuticals Revenue, 2024-2030
6.2.3 By Region - Global PET Radiopharmaceuticals Revenue Market Share, 2018-2030
6.3 By Region - Global PET Radiopharmaceuticals Sales & Forecasts
6.3.1 By Region - Global PET Radiopharmaceuticals Sales, 2018-2023
6.3.2 By Region - Global PET Radiopharmaceuticals Sales, 2024-2030
6.3.3 By Region - Global PET Radiopharmaceuticals Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America PET Radiopharmaceuticals Revenue, 2018-2030
6.4.2 By Country - North America PET Radiopharmaceuticals Sales, 2018-2030
6.4.3 US PET Radiopharmaceuticals Market Size, 2018-2030
6.4.4 Canada PET Radiopharmaceuticals Market Size, 2018-2030
6.4.5 Mexico PET Radiopharmaceuticals Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe PET Radiopharmaceuticals Revenue, 2018-2030
6.5.2 By Country - Europe PET Radiopharmaceuticals Sales, 2018-2030
6.5.3 Germany PET Radiopharmaceuticals Market Size, 2018-2030
6.5.4 France PET Radiopharmaceuticals Market Size, 2018-2030
6.5.5 U.K. PET Radiopharmaceuticals Market Size, 2018-2030
6.5.6 Italy PET Radiopharmaceuticals Market Size, 2018-2030
6.5.7 Russia PET Radiopharmaceuticals Market Size, 2018-2030
6.5.8 Nordic Countries PET Radiopharmaceuticals Market Size, 2018-2030
6.5.9 Benelux PET Radiopharmaceuticals Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia PET Radiopharmaceuticals Revenue, 2018-2030
6.6.2 By Region - Asia PET Radiopharmaceuticals Sales, 2018-2030
6.6.3 China PET Radiopharmaceuticals Market Size, 2018-2030
6.6.4 Japan PET Radiopharmaceuticals Market Size, 2018-2030
6.6.5 South Korea PET Radiopharmaceuticals Market Size, 2018-2030
6.6.6 Southeast Asia PET Radiopharmaceuticals Market Size, 2018-2030
6.6.7 India PET Radiopharmaceuticals Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America PET Radiopharmaceuticals Revenue, 2018-2030
6.7.2 By Country - South America PET Radiopharmaceuticals Sales, 2018-2030
6.7.3 Brazil PET Radiopharmaceuticals Market Size, 2018-2030
6.7.4 Argentina PET Radiopharmaceuticals Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa PET Radiopharmaceuticals Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa PET Radiopharmaceuticals Sales, 2018-2030
6.8.3 Turkey PET Radiopharmaceuticals Market Size, 2018-2030
6.8.4 Israel PET Radiopharmaceuticals Market Size, 2018-2030
6.8.5 Saudi Arabia PET Radiopharmaceuticals Market Size, 2018-2030
6.8.6 UAE PET Radiopharmaceuticals Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Cardinal Health Inc. (U.S.)
7.1.1 Cardinal Health Inc. (U.S.) Company Summary
7.1.2 Cardinal Health Inc. (U.S.) Business Overview
7.1.3 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Major Product Offerings
7.1.4 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.1.5 Cardinal Health Inc. (U.S.) Key News & Latest Developments
7.2 Mallinckrodt plc (Ireland)
7.2.1 Mallinckrodt plc (Ireland) Company Summary
7.2.2 Mallinckrodt plc (Ireland) Business Overview
7.2.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Major Product Offerings
7.2.4 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.2.5 Mallinckrodt plc (Ireland) Key News & Latest Developments
7.3 GE Healthcare (U.K.)
7.3.1 GE Healthcare (U.K.) Company Summary
7.3.2 GE Healthcare (U.K.) Business Overview
7.3.3 GE Healthcare (U.K.) PET Radiopharmaceuticals Major Product Offerings
7.3.4 GE Healthcare (U.K.) PET Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.3.5 GE Healthcare (U.K.) Key News & Latest Developments
7.4 Lantheus Medical Imaging, Inc. (U.S.)
7.4.1 Lantheus Medical Imaging, Inc. (U.S.) Company Summary
7.4.2 Lantheus Medical Imaging, Inc. (U.S.) Business Overview
7.4.3 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Major Product Offerings
7.4.4 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.4.5 Lantheus Medical Imaging, Inc. (U.S.) Key News & Latest Developments
7.5 Bayer AG (Germany)
7.5.1 Bayer AG (Germany) Company Summary
7.5.2 Bayer AG (Germany) Business Overview
7.5.3 Bayer AG (Germany) PET Radiopharmaceuticals Major Product Offerings
7.5.4 Bayer AG (Germany) PET Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.5.5 Bayer AG (Germany) Key News & Latest Developments
7.6 Bracco Imaging S.p.A (Italy)
7.6.1 Bracco Imaging S.p.A (Italy) Company Summary
7.6.2 Bracco Imaging S.p.A (Italy) Business Overview
7.6.3 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Major Product Offerings
7.6.4 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.6.5 Bracco Imaging S.p.A (Italy) Key News & Latest Developments
7.7 Eczacibasi-Monrol Nuclear Products (Turkey)
7.7.1 Eczacibasi-Monrol Nuclear Products (Turkey) Company Summary
7.7.2 Eczacibasi-Monrol Nuclear Products (Turkey) Business Overview
7.7.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Major Product Offerings
7.7.4 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.7.5 Eczacibasi-Monrol Nuclear Products (Turkey) Key News & Latest Developments
7.8 Nordion, Inc. (Canada)
7.8.1 Nordion, Inc. (Canada) Company Summary
7.8.2 Nordion, Inc. (Canada) Business Overview
7.8.3 Nordion, Inc. (Canada) PET Radiopharmaceuticals Major Product Offerings
7.8.4 Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.8.5 Nordion, Inc. (Canada) Key News & Latest Developments
7.9 Advanced Accelerator Applications S.A. (France)
7.9.1 Advanced Accelerator Applications S.A. (France) Company Summary
7.9.2 Advanced Accelerator Applications S.A. (France) Business Overview
7.9.3 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Major Product Offerings
7.9.4 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.9.5 Advanced Accelerator Applications S.A. (France) Key News & Latest Developments
7.10 IBA Molecular Imaging (Belgium)
7.10.1 IBA Molecular Imaging (Belgium) Company Summary
7.10.2 IBA Molecular Imaging (Belgium) Business Overview
7.10.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Major Product Offerings
7.10.4 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.10.5 IBA Molecular Imaging (Belgium) Key News & Latest Developments
8 Global PET Radiopharmaceuticals Production Capacity, Analysis
8.1 Global PET Radiopharmaceuticals Production Capacity, 2018-2030
8.2 PET Radiopharmaceuticals Production Capacity of Key Manufacturers in Global Market
8.3 Global PET Radiopharmaceuticals Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PET Radiopharmaceuticals Supply Chain Analysis
10.1 PET Radiopharmaceuticals Industry Value Chain
10.2 PET Radiopharmaceuticals Upstream Market
10.3 PET Radiopharmaceuticals Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 PET Radiopharmaceuticals Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of PET Radiopharmaceuticals in Global Market
Table 2. Top PET Radiopharmaceuticals Players in Global Market, Ranking by Revenue (2022)
Table 3. Global PET Radiopharmaceuticals Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global PET Radiopharmaceuticals Revenue Share by Companies, 2018-2023
Table 5. Global PET Radiopharmaceuticals Sales by Companies, (K Pcs), 2018-2023
Table 6. Global PET Radiopharmaceuticals Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers PET Radiopharmaceuticals Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers PET Radiopharmaceuticals Product Type
Table 9. List of Global Tier 1 PET Radiopharmaceuticals Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 PET Radiopharmaceuticals Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global PET Radiopharmaceuticals Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global PET Radiopharmaceuticals Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global PET Radiopharmaceuticals Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global PET Radiopharmaceuticals Sales (K Pcs), 2018-2023
Table 15. By Type - Global PET Radiopharmaceuticals Sales (K Pcs), 2024-2030
Table 16. By Application ? Global PET Radiopharmaceuticals Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global PET Radiopharmaceuticals Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global PET Radiopharmaceuticals Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global PET Radiopharmaceuticals Sales (K Pcs), 2018-2023
Table 20. By Application - Global PET Radiopharmaceuticals Sales (K Pcs), 2024-2030
Table 21. By Region ? Global PET Radiopharmaceuticals Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global PET Radiopharmaceuticals Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global PET Radiopharmaceuticals Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global PET Radiopharmaceuticals Sales (K Pcs), 2018-2023
Table 25. By Region - Global PET Radiopharmaceuticals Sales (K Pcs), 2024-2030
Table 26. By Country - North America PET Radiopharmaceuticals Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America PET Radiopharmaceuticals Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America PET Radiopharmaceuticals Sales, (K Pcs), 2018-2023
Table 29. By Country - North America PET Radiopharmaceuticals Sales, (K Pcs), 2024-2030
Table 30. By Country - Europe PET Radiopharmaceuticals Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe PET Radiopharmaceuticals Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe PET Radiopharmaceuticals Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe PET Radiopharmaceuticals Sales, (K Pcs), 2024-2030
Table 34. By Region - Asia PET Radiopharmaceuticals Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia PET Radiopharmaceuticals Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia PET Radiopharmaceuticals Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia PET Radiopharmaceuticals Sales, (K Pcs), 2024-2030
Table 38. By Country - South America PET Radiopharmaceuticals Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America PET Radiopharmaceuticals Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America PET Radiopharmaceuticals Sales, (K Pcs), 2018-2023
Table 41. By Country - South America PET Radiopharmaceuticals Sales, (K Pcs), 2024-2030
Table 42. By Country - Middle East & Africa PET Radiopharmaceuticals Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa PET Radiopharmaceuticals Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa PET Radiopharmaceuticals Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa PET Radiopharmaceuticals Sales, (K Pcs), 2024-2030
Table 46. Cardinal Health Inc. (U.S.) Company Summary
Table 47. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Offerings
Table 48. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Cardinal Health Inc. (U.S.) Key News & Latest Developments
Table 50. Mallinckrodt plc (Ireland) Company Summary
Table 51. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Offerings
Table 52. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Mallinckrodt plc (Ireland) Key News & Latest Developments
Table 54. GE Healthcare (U.K.) Company Summary
Table 55. GE Healthcare (U.K.) PET Radiopharmaceuticals Product Offerings
Table 56. GE Healthcare (U.K.) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. GE Healthcare (U.K.) Key News & Latest Developments
Table 58. Lantheus Medical Imaging, Inc. (U.S.) Company Summary
Table 59. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Offerings
Table 60. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. Lantheus Medical Imaging, Inc. (U.S.) Key News & Latest Developments
Table 62. Bayer AG (Germany) Company Summary
Table 63. Bayer AG (Germany) PET Radiopharmaceuticals Product Offerings
Table 64. Bayer AG (Germany) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. Bayer AG (Germany) Key News & Latest Developments
Table 66. Bracco Imaging S.p.A (Italy) Company Summary
Table 67. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Offerings
Table 68. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. Bracco Imaging S.p.A (Italy) Key News & Latest Developments
Table 70. Eczacibasi-Monrol Nuclear Products (Turkey) Company Summary
Table 71. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Offerings
Table 72. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. Eczacibasi-Monrol Nuclear Products (Turkey) Key News & Latest Developments
Table 74. Nordion, Inc. (Canada) Company Summary
Table 75. Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Offerings
Table 76. Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. Nordion, Inc. (Canada) Key News & Latest Developments
Table 78. Advanced Accelerator Applications S.A. (France) Company Summary
Table 79. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Offerings
Table 80. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 81. Advanced Accelerator Applications S.A. (France) Key News & Latest Developments
Table 82. IBA Molecular Imaging (Belgium) Company Summary
Table 83. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Offerings
Table 84. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 85. IBA Molecular Imaging (Belgium) Key News & Latest Developments
Table 86. PET Radiopharmaceuticals Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 87. Global PET Radiopharmaceuticals Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global PET Radiopharmaceuticals Production by Region, 2018-2023 (K Pcs)
Table 89. Global PET Radiopharmaceuticals Production by Region, 2024-2030 (K Pcs)
Table 90. PET Radiopharmaceuticals Market Opportunities & Trends in Global Market
Table 91. PET Radiopharmaceuticals Market Drivers in Global Market
Table 92. PET Radiopharmaceuticals Market Restraints in Global Market
Table 93. PET Radiopharmaceuticals Raw Materials
Table 94. PET Radiopharmaceuticals Raw Materials Suppliers in Global Market
Table 95. Typical PET Radiopharmaceuticals Downstream
Table 96. PET Radiopharmaceuticals Downstream Clients in Global Market
Table 97. PET Radiopharmaceuticals Distributors and Sales Agents in Global Market
List of Figures
Figure 1. PET Radiopharmaceuticals Segment by Type in 2022
Figure 2. PET Radiopharmaceuticals Segment by Application in 2022
Figure 3. Global PET Radiopharmaceuticals Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global PET Radiopharmaceuticals Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global PET Radiopharmaceuticals Revenue, 2018-2030 (US$, Mn)
Figure 7. PET Radiopharmaceuticals Sales in Global Market: 2018-2030 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by PET Radiopharmaceuticals Revenue in 2022
Figure 9. By Type - Global PET Radiopharmaceuticals Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global PET Radiopharmaceuticals Revenue Market Share, 2018-2030
Figure 11. By Type - Global PET Radiopharmaceuticals Sales Market Share, 2018-2030
Figure 12. By Type - Global PET Radiopharmaceuticals Price (USD/Pcs), 2018-2030
Figure 13. By Application - Global PET Radiopharmaceuticals Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global PET Radiopharmaceuticals Revenue Market Share, 2018-2030
Figure 15. By Application - Global PET Radiopharmaceuticals Sales Market Share, 2018-2030
Figure 16. By Application - Global PET Radiopharmaceuticals Price (USD/Pcs), 2018-2030
Figure 17. By Region - Global PET Radiopharmaceuticals Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global PET Radiopharmaceuticals Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global PET Radiopharmaceuticals Revenue Market Share, 2018-2030
Figure 20. By Region - Global PET Radiopharmaceuticals Sales Market Share, 2018-2030
Figure 21. By Country - North America PET Radiopharmaceuticals Revenue Market Share, 2018-2030
Figure 22. By Country - North America PET Radiopharmaceuticals Sales Market Share, 2018-2030
Figure 23. US PET Radiopharmaceuticals Revenue, (US$, Mn), 2018-2030
Figure 24. Canada PET Radiopharmaceuticals Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico PET Radiopharmaceuticals Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe PET Radiopharmaceuticals Revenue Market Share, 2018-2030
Figure 27. By Country - Europe PET Radiopharmaceuticals Sales Market Share, 2018-2030
Figure 28. Germany PET Radiopharmaceuticals Revenue, (US$, Mn), 2018-2030
Figure 29. France PET Radiopharmaceuticals Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. PET Radiopharmaceuticals Revenue, (US$, Mn), 2018-2030
Figure 31. Italy PET Radiopharmaceuticals Revenue, (US$, Mn), 2018-2030
Figure 32. Russia PET Radiopharmaceuticals Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries PET Radiopharmaceuticals Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux PET Radiopharmaceuticals Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia PET Radiopharmaceuticals Revenue Market Share, 2018-2030
Figure 36. By Region - Asia PET Radiopharmaceuticals Sales Market Share, 2018-2030
Figure 37. China PET Radiopharmaceuticals Revenue, (US$, Mn), 2018-2030
Figure 38. Japan PET Radiopharmaceuticals Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea PET Radiopharmaceuticals Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia PET Radiopharmaceuticals Revenue, (US$, Mn), 2018-2030
Figure 41. India PET Radiopharmaceuticals Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America PET Radiopharmaceuticals Revenue Market Share, 2018-2030
Figure 43. By Country - South America PET Radiopharmaceuticals Sales Market Share, 2018-2030
Figure 44. Brazil PET Radiopharmaceuticals Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina PET Radiopharmaceuticals Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa PET Radiopharmaceuticals Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa PET Radiopharmaceuticals Sales Market Share, 2018-2030
Figure 48. Turkey PET Radiopharmaceuticals Revenue, (US$, Mn), 2018-2030
Figure 49. Israel PET Radiopharmaceuticals Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia PET Radiopharmaceuticals Revenue, (US$, Mn), 2018-2030
Figure 51. UAE PET Radiopharmaceuticals Revenue, (US$, Mn), 2018-2030
Figure 52. Global PET Radiopharmaceuticals Production Capacity (K Pcs), 2018-2030
Figure 53. The Percentage of Production PET Radiopharmaceuticals by Region, 2022 VS 2030
Figure 54. PET Radiopharmaceuticals Industry Value Chain
Figure 55. Marketing Channels
